BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10634413)

  • 1. Studies on human pregnancy-induced insulin-like growth factor (IGF)-binding protein-4 proteases in serum: determination of IGF-II dependency and localization of cleavage site.
    Byun D; Mohan S; Kim C; Suh K; Yoo M; Lee H; Baylink DJ; Qin X
    J Clin Endocrinol Metab; 2000 Jan; 85(1):373-81. PubMed ID: 10634413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease.
    Qin X; Byun D; Lau KH; Baylink DJ; Mohan S
    Arch Biochem Biophys; 2000 Jul; 379(2):209-16. PubMed ID: 10898936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs.
    Qin X; Byun D; Strong DD; Baylink DJ; Mohan S
    J Bone Miner Res; 1999 Dec; 14(12):2079-88. PubMed ID: 10620067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro.
    Byun D; Mohan S; Yoo M; Sexton C; Baylink DJ; Qin X
    J Clin Endocrinol Metab; 2001 Feb; 86(2):847-54. PubMed ID: 11158056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: regulation by transforming growth factor-beta.
    Durham SK; Riggs BL; Conover CA
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1752-8. PubMed ID: 7527411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis of insulin-like growth factor binding proteins by a novel 50-kilodalton metalloproteinase in human pregnancy serum.
    Kübler B; Cowell S; Zapf J; Braulke T
    Endocrinology; 1998 Apr; 139(4):1556-63. PubMed ID: 9528934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of insulin-like growth factor-modulated proteolysis of insulin-like growth factor binding protein-4 and -5 by pregnancy-associated plasma protein-A.
    Gyrup C; Oxvig C
    Biochemistry; 2007 Feb; 46(7):1972-80. PubMed ID: 17249697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-associated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane.
    Sun IY; Overgaard MT; Oxvig C; Giudice LC
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5235-40. PubMed ID: 12414897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation.
    Giudice LC; Conover CA; Bale L; Faessen GH; Ilg K; Sun I; Imani B; Suen LF; Irwin JC; Christiansen M; Overgaard MT; Oxvig C
    J Clin Endocrinol Metab; 2002 May; 87(5):2359-66. PubMed ID: 11994388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells.
    Parker A; Gockerman A; Busby WH; Clemmons DR
    Endocrinology; 1995 Jun; 136(6):2470-6. PubMed ID: 7538463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
    Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
    J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
    Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
    Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of insulin-like growth factor binding protein-1, -3 and -4 in human fetal tissues and their analysis in media from fetal tissue explants.
    Braulke T; Götz W; Claussen M
    Growth Regul; 1996 Jun; 6(2):55-65. PubMed ID: 8781981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
    Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH
    J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism.
    Miyakoshi N; Qin X; Kasukawa Y; Richman C; Srivastava AK; Baylink DJ; Mohan S
    Endocrinology; 2001 Jun; 142(6):2641-8. PubMed ID: 11356715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
    Durham SK; Kiefer MC; Riggs BL; Conover CA
    J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis.
    Fowlkes JL; Serra DM; Rosenberg CK; Thrailkill KM
    J Biol Chem; 1995 Nov; 270(46):27481-8. PubMed ID: 7499205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A.
    Lawrence JB; Oxvig C; Overgaard MT; Sottrup-Jensen L; Gleich GJ; Hays LG; Yates JR; Conover CA
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3149-53. PubMed ID: 10077652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
    Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
    Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions.
    Rees C; Clemmons DR; Horvitz GD; Clarke JB; Busby WH
    Endocrinology; 1998 Oct; 139(10):4182-8. PubMed ID: 9751498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.